Capstone Investment Advisors »

Ptc Therapeutics shares owned by Capstone Investment Advisors

Quarter-by-quarter ownership of Ptc Therapeutics shares owned by Capstone Investment Advisors from 13F filings

Historical chart of Capstone Investment Advisors investment in Ptc Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Ptc Therapeutics held by Capstone Investment Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ptc Therapeutics by Capstone Investment Advisors

Quarter filed Position value Share count Share price at filing
2025-09-30 $26M 20M 1.29
2025-06-30 $8.7M 7.5M 1.16

More positions owned by Capstone Investment Advisors

Spdr S&p 500 Etf Tr Tr Unit (SPY)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Tesla Motors (TSLA)
Amazon (AMZN)
Ishares Tr Russell 2000 Etf (IWM)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Apple (AAPL)
Advanced Micro Devices (AMD)
Alphabet Cap Stk Cl A (GOOGL)
Meta Platforms Cl A (META)
Ishares Tr Core S&p500 Etf (IVV)
Ishares Tr Msci Emg Mkt Etf (EEM)
Select Sector Spdr Tr Financial (XLF)
Broadcom (AVGO)

View all positions for Capstone Investment Advisors

Top funds holding Ptc Therapeutics

Franklin Resources
Lazard Asset Management
Tenor Capital Management
DeepCurrents Investment Group
D. E. Shaw & Co
Capstone Investment Advisors
Linden Advisors
Whitebox Advisors
CSS
Camden Asset Management
SSI Investment Management
BlackRock
Kornitzer Capital Management
Central Pacific Bank - Trust Division

View all funds holding Ptc Therapeutics